Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

17. Immunologic endocrine disorders.

Devasenan Devendra1, George S Eisenbarth

  • 1Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, 4200 East 9th Avenue, Denver, CO 80262, USA.

The Journal of Allergy and Clinical Immunology
|February 20, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ambient Voice Technology in Same Day Emergency Care: Enhancing Documentation Efficiency and Patient Flow.

Acute medicine·2025
Same author

HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 Haplotype Protects Autoantibody-Positive Relatives From Type 1 Diabetes Throughout the Stages of Disease Progression.

Diabetes·2016
Same author

Novel Association Between Immune-Mediated Susceptibility Loci and Persistent Autoantibody Positivity in Type 1 Diabetes.

Diabetes·2015
Same author

Risk of pediatric celiac disease according to HLA haplotype and country.

The New England journal of medicine·2014
Same author

γδ T cells recognize the insulin B:9-23 peptide antigen when it is dimerized through thiol oxidation.

Molecular immunology·2014
Same author

MAS-1 adjuvant immunotherapy generates robust Th2 type and regulatory immune responses providing long-term protection from diabetes in late-stage pre-diabetic NOD mice.

Autoimmunity·2014
Same journal

Tamoxifen-driven neutrophil reprogramming protects from pulmonary Granulibacter bethesdensis infection in chronic granulomatous disease.

The Journal of allergy and clinical immunology·2026
Same journal

Clinical and transcriptomic characterization of mixed granulocytic COPD phenotype.

The Journal of allergy and clinical immunology·2026
Same journal

Dupilumab outcomes in pediatric asthma by early eosinophil status: post hoc analysis of VOYAGE/EXCURSION.

The Journal of allergy and clinical immunology·2026
Same journal

Maternal antibiotic exposure alters the newborn metabolomic profile and increases the risk of respiratory infections in offspring: a 13-year longitudinal birth cohort study.

The Journal of allergy and clinical immunology·2026
Same journal

Selective Elimination of Mast Cells via Siglec-6-Targeted Nanodelivery of Drug Payload.

The Journal of allergy and clinical immunology·2026
Same journal

Loss of epidermal miR-149 sensitizes to skin inflammation.

The Journal of allergy and clinical immunology·2026
See all related articles

Understanding the immunogenetics of endocrine disorders is key to preventing disease. Research into genetic susceptibility and autoimmunity offers new avenues for early detection and intervention strategies.

Area of Science:

  • Endocrinology
  • Immunology
  • Genetics

Background:

  • Immune-mediated processes cause common and rare endocrine disorders like type 1 diabetes, Graves' disease, Hashimoto thyroiditis, and Addison's disease.
  • These diseases progress through stages: genetic susceptibility, environmental triggers, autoimmunity, and overt metabolic disease.
  • Genetic factors, including HLA region and transcription factor mutations, contribute significantly to disease susceptibility.

Purpose of the Study:

  • To explore the immunogenetics and immunopathogenesis of endocrine disorders.
  • To highlight the stages of immune-mediated endocrine diseases.
  • To emphasize the potential for understanding these mechanisms to prevent disease-related morbidity and mortality.

Main Methods:

  • Review of existing literature on the immunogenetics and immunopathogenesis of endocrine disorders.

Related Experiment Videos

  • Analysis of disease progression stages from genetic susceptibility to overt disease.
  • Examination of autoantibody screening assays and animal model studies.

    • Main Results:

    • Type 1A diabetes is now predictable due to advances in immunogenetic and pathogenic understanding.
    • Autoantibody screening assays are available for early detection.
    • Aberrant immune reactions can complicate standard and experimental therapies.

    Conclusions:

    • Understanding the immunogenetics and immunopathogenesis of endocrine disorders is crucial.
    • This knowledge aids in predicting disease onset and developing preventive strategies.
    • Further research can lead to reduced morbidity and mortality associated with these conditions.